Vergouwe Y - Search Results

1

Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review.

Vergouwe Y, Steyerberg EW, Eijkemans MJ, Albers P, Habbema JD. Vergouwe Y, et al. J Clin Oncol. 2003 Nov 15;21(22):4092-9. doi: 10.1200/JCO.2003.01.094. Epub 2003 Oct 14. J Clin Oncol. 2003. PMID: 14559885

2

Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer.

Vergouwe Y, Steyerberg EW, Foster RS, Habbema JD, Donohue JP. Vergouwe Y, et al. J Urol. 2001 Jan;165(1):84-8; discussion 88. doi: 10.1097/00005392-200101000-00021. J Urol. 2001. PMID: 11125370

3

Validity of prognostic models: when is a model clinically useful?

Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD. Vergouwe Y, et al. Semin Urol Oncol. 2002 May;20(2):96-107. doi: 10.1053/suro.2002.32521. Semin Urol Oncol. 2002. PMID: 12012295

4

Validation of two risk models for perioperative mortality in patients undergoing elective abdominal aortic aneurysm surgery.

Kertai MD, Steyerberg EW, Boersma E, Bax JJ, Vergouwe Y, van Urk H, Habbema JD, Roelandt JR, Poldermans D. Kertai MD, et al. Among authors: vergouwe y. Vasc Endovascular Surg. 2003 Jan-Feb;37(1):13-21. doi: 10.1177/153857440303700102. Vasc Endovascular Surg. 2003. PMID: 12577134

5

Substantial effective sample sizes were required for external validation studies of predictive logistic regression models.

Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD. Vergouwe Y, et al. J Clin Epidemiol. 2005 May;58(5):475-83. doi: 10.1016/j.jclinepi.2004.06.017. J Clin Epidemiol. 2005. PMID: 15845334

6

Minimal residual tumor masses in nonseminomatous testicular cancer: surgery or surveillance?

Vergouwe Y, Steyerberg EW. Vergouwe Y, et al. J Clin Oncol. 2005 Jun 1;23(16):3853. doi: 10.1200/JCO.2005.05.320. J Clin Oncol. 2005. PMID: 15923581 No abstract available.

7

Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.

Vergouwe Y, Steyerberg EW, Foster RS, Sleijfer DT, Fosså SD, Gerl A, de Wit R, Roberts JT, Habbema JD. Vergouwe Y, et al. Eur Urol. 2007 Feb;51(2):424-32. doi: 10.1016/j.eururo.2006.06.047. Epub 2006 Jul 14. Eur Urol. 2007. PMID: 16911854

8

Interpretation of concordance measures for clustered data.

van Klaveren D, Steyerberg EW, Vergouwe Y. van Klaveren D, et al. Among authors: vergouwe y. Stat Med. 2014 Feb 20;33(4):714-6. doi: 10.1002/sim.5928. Stat Med. 2014. PMID: 24425541 No abstract available.

9

Towards better clinical prediction models: seven steps for development and an ABCD for validation.

Steyerberg EW, Vergouwe Y. Steyerberg EW, et al. Among authors: vergouwe y. Eur Heart J. 2014 Aug 1;35(29):1925-31. doi: 10.1093/eurheartj/ehu207. Epub 2014 Jun 4. Eur Heart J. 2014. PMID: 24898551 Free PMC article.

10

A head to head comparison of nine tools predicting non-sentinel lymph node status in sentinel node positive breast cancer women.

van den Hoven I, Kuijt G, Roumen R, Voogd A, Steyerberg EW, Vergouwe Y. van den Hoven I, et al. Among authors: vergouwe y. J Surg Oncol. 2015 Aug;112(2):133-8. doi: 10.1002/jso.23992. Epub 2015 Aug 10. J Surg Oncol. 2015. PMID: 26258749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters